Publications & Posters
Scholarly publications
Spinal Muscular Atrophy
Apitegromab
March 2026
SMA Europe 2026
Understanding physical therapist perspectives on the clinical meaningfulness of ‘any point differences’ on the Hammersmith Functional Motor Scale-Expanded in SMA
Spinal Muscular Atrophy
Apitegromab
March 2026
SMA Europe 2026
Understanding neurologist perspectives on the clinical meaningfulness of ‘any point differences’ on the Hammersmith Functional Motor Scale-Expanded in SMA
Facioscapulohumeral Muscular Dystrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
Trial design for the Phase 2 FORGE study evaluating apitegromab in adults with facioscapulohumeral muscular dystrophy
Facioscapulohumeral Muscular Dystrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
muSRK-015 Improves Muscle Function and Biomarkers in the FLExDUX4 Mouse Model of FSHD
Spinal Muscular Atrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
Meaningfulness of ‘any point change’ or ‘stabilization’ in the HFMSE on the psychosocial well-being of adult patients with spinal muscular atrophy
Spinal Muscular Atrophy
Apitegromab
March 2026
Muscular Dystrophy Association Clinical & Scientific Conference 2026
